Assessment of abuse and related factors in older patients with cancer

ArticleAçık Erişim

Özet

Background: Older cancer patients are more likely to present with functional dependency, multiple comorbidities, polypharmacy, malnutrition, and cognitive dysfunction than their younger counterparts which increases the risk of elder abuse. Herein, in this single-institution observational study, we aimed to determine the frequency and risk factors of abuse in cancer patients aged 70 and above. Methods: A total of 217 cancer patients aged ≥ 70 years who applied to the medical oncology outpatient clinic between June 2020 and January 2021 were included in this study. Informed consent was obtained before data collection. The Hwalek-Sengstock Elder Abuse Screening Test (H–S/EAST) was used to evaluate elder abuse. Sociodemographic characteristics and clinical measurements were collected. Results: The mean age was 75.5, and 59.4% were male. The prevalence of abuse risk in older patients with cancer was 39.2%. In the multivariate logistic regression model, applying to the outpatient clinic for treatment (OR: 3.369, 95% CI: 1.455–7.802, p = 0.005), living in urban (OR: 5.787, 95% CI: 2.377–14.090, p < 0.001), history of falls (OR: 4.587, 95% CI: 1.789–11.762, p = 0.002), and being depressed according to the Geriatric Depression Scale-15 (GDS-15) score (OR: 10.788, 95% CI: 4.491–25.914, p < 0.001) were associated with an increased risk of elder abuse. Primary/junior education level and high school/university education level were protective against elder abuse risk compared to being illiterate (OR: 0.073, 95% CI: 0.025–0.210 and OR: 0.213, 95% CI: 0.056–0.806, respectively). Conclusion: Cancer patients aged ≥ 70 years had a high risk of elder abuse. Elder abuse should be screened in patients with cancer, and the effects of this phenomenon on cancer care should be investigated in larger studies. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13435Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s00520-021-06391-7Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAkagunduz, Baran
dc.contributor.authorAltın, Zeynep
dc.contributor.authorAtcı, Muhammed Mustafa
dc.contributor.authorOzer, Muhammet
dc.contributor.authorGüven, Deniz Can
dc.contributor.authorÇil, İbrahim
dc.contributor.authorÖzçiçek, Fatih
dc.contributor.authorDemirtaş, Levent
dc.contributor.authorDuzgun, Eren
dc.contributor.authorGunderci, Azad
dc.contributor.authorArslan, Yusuf
dc.date.accessioned2026-10-18T20:28:15.910071202Z
dc.date.available2026-10-18T20:28:15.910071202Z
dc.date.issued2021
dc.description.abstractBackground: Older cancer patients are more likely to present with functional dependency, multiple comorbidities, polypharmacy, malnutrition, and cognitive dysfunction than their younger counterparts which increases the risk of elder abuse. Herein, in this single-institution observational study, we aimed to determine the frequency and risk factors of abuse in cancer patients aged 70 and above. Methods: A total of 217 cancer patients aged ≥ 70 years who applied to the medical oncology outpatient clinic between June 2020 and January 2021 were included in this study. Informed consent was obtained before data collection. The Hwalek-Sengstock Elder Abuse Screening Test (H–S/EAST) was used to evaluate elder abuse. Sociodemographic characteristics and clinical measurements were collected. Results: The mean age was 75.5, and 59.4% were male. The prevalence of abuse risk in older patients with cancer was 39.2%. In the multivariate logistic regression model, applying to the outpatient clinic for treatment (OR: 3.369, 95% CI: 1.455–7.802, p = 0.005), living in urban (OR: 5.787, 95% CI: 2.377–14.090, p < 0.001), history of falls (OR: 4.587, 95% CI: 1.789–11.762, p = 0.002), and being depressed according to the Geriatric Depression Scale-15 (GDS-15) score (OR: 10.788, 95% CI: 4.491–25.914, p < 0.001) were associated with an increased risk of elder abuse. Primary/junior education level and high school/university education level were protective against elder abuse risk compared to being illiterate (OR: 0.073, 95% CI: 0.025–0.210 and OR: 0.213, 95% CI: 0.056–0.806, respectively). Conclusion: Cancer patients aged ≥ 70 years had a high risk of elder abuse. Elder abuse should be screened in patients with cancer, and the effects of this phenomenon on cancer care should be investigated in larger studies. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
dc.identifier.doi10.1007/s00520-021-06391-7
dc.identifier.endpage7964
dc.identifier.issn0941-4355
dc.identifier.issue12
dc.identifier.pmid34213643
dc.identifier.scopus2-s2.0-85109269579
dc.identifier.startpage7957
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13435
dc.identifier.volume29
dc.language.isoen
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relation.ispartofSupportive Care in Cancer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCancer
dc.subjectElder abuse
dc.subjectRisk factors
dc.subjectAged
dc.subjectCross-Sectional Studies
dc.subjectEducational Status
dc.subjectHumans
dc.subjectMale
dc.subjectNeoplasms
dc.subjectPrevalence
dc.subjectarticle
dc.subjectcancer patient
dc.subjectcontrolled study
dc.subjectdemography
dc.subjectfemale
dc.subjectGeriatric Depression Scale
dc.subjecthigh school
dc.subjecthuman
dc.subjectinformed consent
dc.subjectmajor clinical study
dc.subjectobservational study
dc.subjectoutpatient department
dc.subjectrisk assessment
dc.subjectrisk factor
dc.subjectscreening test
dc.subjectcross-sectional study
dc.subjectneoplasm
dc.titleAssessment of abuse and related factors in older patients with cancer
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.departmentDepartment of Medical Oncology, Erzincan Binali Yıldrıım University Medical School, 24000, Erzincan, Turkey. drbaran04@hotmail.com. | Department of Internal Medicine, Erzincan Binali Yıldrıım University Medical School, 24000, Erzincan, Turkey. | Department of Biostatistics, Erzincan Binali Yıldrıım University Medical School, 24000, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexPUBMED